课题基金 / 基金详情

Proteinase-Activated Receptor-2 Agonists as Adjuvants for Mucosal Vaccination

Proteinase-Activated Receptor-2 Agonists as Adjuvants for Mucosal Vaccination
蛋白酶激活受体 2 激动剂作为粘膜疫苗佐剂
批准号:
435452
负责人:
Vliagoftis Harissios
金额:
$72.73万
依托单位:
依托单位国家:
加拿大
项目类别:
Operating Grants
财政年份:
2020
资助国家:
加拿大
项目状态:
未结题
起止时间:
2020-10-01 至 2025-10-01

项目摘要

项目成果

Vliagoftis Harissios的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The flu is a lung disease caused by infection with the influenza virus. Flu infections are very common during the winter months and can cause death in vulnerable people such as the very young, the very old, and those with chronic diseases. One way to decr
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Acute airway inflammation induced by vaping
  • 批准号:
    425157
  • 项目类别:
    Operating Grants
  • 资助金额:
    $7.28万
  • 财政年份:
    2020
  • 负责人:
    Vliagoftis Harissios
  • 依托单位:
Proteinase-Activated Receptors as a therapeutic target in allergic inflammation
  • 批准号:
    328217
  • 项目类别:
    Salary Programs
  • 资助金额:
    $6.19万
  • 财政年份:
    2015
  • 负责人:
    Vliagoftis Harissios
  • 依托单位:
Proteinase-Activated Receptors as a therapeutic target in allergic inflammation
  • 批准号:
    330169
  • 项目类别:
    Operating Grants
  • 资助金额:
    $9.11万
  • 财政年份:
    2015
  • 负责人:
    Vliagoftis Harissios
  • 依托单位:
Proteinase-Activated Receptor-2 (PAR-2) as a therapeutic target for allergic airway inflammation
  • 批准号:
    292162
  • 项目类别:
    Operating Grants
  • 资助金额:
    $49.8万
  • 财政年份:
    2013
  • 负责人:
    Vliagoftis Harissios
  • 依托单位:
海外基金